期刊文献+

非小细胞肺癌p14^(ARF) p16^(INK4a)蛋白共表达及其临床意义 被引量:6

The Co-expression and Clinical Significance of p14^(ARF) and p16^(INK4a) Proteins in Non-small Cell Lung Cancer
在线阅读 下载PDF
导出
摘要 目的:探讨p14ARF、p16INK4a蛋白在非小细胞肺癌(NSCLC)组织中的表达、意义及相关关系。方法:采用免疫组织化学SP方法对103例NSCLC组织中p14ARF和p16INK4a蛋白的表达进行检测。结果:103例NSCLC组织中p14ARF、p16INK4a蛋白表达阴性率分别为70.87%和43.69%,差异有显著性(P<0.01)。其中35例p14ARF、p16INK4a蛋白表达共阴性,共阴性率达33.98%(35/103),鳞癌中共阴性率明显高于其它组织类型(P<0.01)。p14ARF、p16INK4a蛋白表达阴性相互间无显著相关性(P>0.05)。临床Ⅲ+Ⅳ期病例两种蛋白表达阴性率明显高于临床Ⅰ+Ⅱ期(P<0.05)。结论:NSCLC组织p14ARF、p16INK4a蛋白表达共阴性具有明显的组织学类型特异性,两种蛋白阴性表达是各自独立的事件。 Objective: To study the expression and clinical significance of p14^ARF and p16^INK4a proteins and to explore the eorrelationship between negative expressions of p14^ARF and p16^INK4a proteins in non-small cell lung cancer (NSCLC). Methods: The expressions of p14^ARF and p16^INK4a proteins were detected in 103 NSCLC samples by immunohistochemistry (S-P method). Results: The negative expression of p14^ARF was detected in 73 (70.87%) of the 103 NSCLC cases. The other 30 cases showed positive immunohistochemical result. While the negative expression of pl61NK4"was detected in 45 (43.69%) of 103 NSCLC cases. The other 58 cases showed positive immunohistochemical result. There was a significant difference between the negative rate of p1^ARF expression and of p16^INK4a expressions (P〈0.01). In 103 NSCLC, 35 cases (33.98%) showed simultaneous loss in both proteins. The negative rates of p14^ARF and p16^INK4a co-expressions in squamous cell carcinoma, adenocarcinoma and bronchioloalveolar carcinoma were 55.88% (19/34), 27.27% (9/33) and 19.44% (7/36), respectively, and the squarnous cell carcinoma group was significantly higher compared to the others (P〈0.01). Rank correlation analysis revealed that there was no correlation between negative expression of p14ARv and of p16^INK4a proteins in NSCLC (P〉0.05). Of the 65 samples analyzed from NSCLC patients, the negative rate of p14^ARF and p16^INK4a expressions were 54.05%(20/37) and 35.14%(13/37) in the groups of clinical stage Ⅰ +Ⅱ respectively, the negative rate of p14^ARF and p16^INK4a expressions were 78.57%(22/28) and 60.71%(17/28) in the groups of clinical stage Ⅲ + Ⅳ respectively. Either p14^ARF and p16^INK4a negative expression was closely related to clinical stage (P〈0.05). Conclusion: Expression alteration of INK4a-ARF gene has the tendency of histopathological specificity. Moreover, there is no correlation between negative expression of p14^ARF and p16^INK4a proteins in NSCLC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第18期1021-1024,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30170293)
关键词 非小细胞肺癌 免疫组织化学 蛋白表达 P14^ARF P16^INK4A Non-small cell lung cancer Immunohistochemistry Protein expression p14^ARF p16^INK4a
  • 相关文献

参考文献10

  • 1Xue Q, Sano T, Kashiwabara K, et al. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung[J]. Pathol Int, 2002, 52(2): 103~109.
  • 2Jin M, Inoue S, Umemura T, et al. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages Ⅰ and Ⅱ [J]. Lung Cancer, 2001, 34(2): 207~218.
  • 3Vonlanthen S, Heighway J, Tschan MP, et al. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression[J]. Oncogene, 1998, 17(21): 2779~2785.
  • 4Gibson SL, Dai CY, Lee HW, et al. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus [J]. Cancer Res, 2003, 63(4): 742~746.
  • 5McKay JA, Douglas JJ, Ross VG, et al. Analysis of key cell-cycle checkpoint proteins in colorectal tumours [J]. J Pathol, 2002, 196(4): 386~393.
  • 6胡义德,高楠,曹世龙.肺癌INK4a/ARF基因缺失与突变研究进展[J].国外医学(呼吸系统分册),2000,20(2):102-103. 被引量:7
  • 7高楠,胡义德,周决,曹晓运,曹世龙.肺癌p14ARF和p16INK4a基因协同表达缺失及其意义[J].中国癌症杂志,2000,10(1):15-18. 被引量:4
  • 8Silva J, Silva JM, Dominguez G, et al. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms[J].J Pathol, 2003, 199(3): 289~297.
  • 9Dominguez G, Silva J, Garcia JM, et al. Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors [J]. Mutat Res, 2003, 530 (1-2): 9 ~ 17.
  • 10Gessner C, Liebers U, Kuhn H, et al. BAX and p16INK4a are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer [J]. Eur RespirJ, 2002, 19(1):134~140.

二级参考文献7

共引文献9

同被引文献57

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部